Literature DB >> 29241783

Botulinum toxin type A for the treatment of localized recalcitrant chronic pruritus.

Emily Boozalis1, Mary Sheu1, Jacqueline Selph1, Shawn G Kwatra2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29241783     DOI： 10.1016/j.jaad.2017.08.001

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

Review 1.  Interventions in the B-type natriuretic peptide signalling pathway as a means of controlling chronic itch.

Authors:  Jianghui Meng; Weiwei Chen; Jiafu Wang
Journal:  Br J Pharmacol       Date:  2020-02-12       Impact factor: 8.739

Review 2.  Antipruritic Effects of Botulinum Neurotoxins.

Authors:  Parisa Gazerani
Journal:  Toxins (Basel)       Date:  2018-03-29       Impact factor: 4.546

Review 3.  Emerging Therapeutic Options for Chronic Pruritus.

Authors:  Radomir Reszke; Piotr Krajewski; Jacek C Szepietowski
Journal:  Am J Clin Dermatol       Date:  2020-10       Impact factor: 7.403

Review 4.  Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects.

Authors:  Hao-Jui Weng; Quoc Thao Trang Pham; Chia-Wei Chang; Tsen-Fang Tsai
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-19

Review 5.  Neuropathic Itch.

Authors:  James Meixiong; Xinzhong Dong; Hao-Jui Weng
Journal:  Cells       Date:  2020-10-09       Impact factor: 6.600
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.